What's Kevin Ju­dice cook­ing up at DiCE now that he's stashed an ex­tra $60M?

DiCE Mol­e­cules CEO Kevin Ju­dice start­ed this year with an $80 mil­lion raise, a clear time­line for jump­ing in­to the clin­ic and a hir­ing no­tice with plans to swell the staff.

So what to make of this bare-bones $60 mil­lion fol­low-up post that in­cludes some well-known crossover in­vestors mak­ing hay from the open IPO win­dow, un­adorned by any quotes or plans?

That by it­self may not count as the clas­sic pre-IPO megaround, but with $140 mil­lion har­vest­ed this year, one could eas­i­ly start draw­ing con­clu­sions about pub­lic mar­ket plan­ning.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER